SkinScreener app analytics for January 3

The incidence of skin cancer has increased steadily worldwide in recent years. Statistically, the probability of developing skin cancer once in a lifetime is about 20%. Early detection is of extreme importance. The earlier skin cancer can be detected, the better the chances of recovery. This is why our group of dermatologists and biomedical engineers have developed SkinScreener, a smart way to determine the personal risk of altered skin areas with an app, in addition to regular dermatological examinations. A clinical study at the Medical University of Graz (using more than 1500 images of real patients) has proven that SkinScreener has an impressive 95% accuracy rate in the detection of skin cancer. SkinScreener is a user-friendly app, developed and clinically proven by a team of dermatologists, physicians, and biomedical engineers. SkinScreener enables a quick assessment of the risk of skin cancer in the case of skin lesions (moles, skin spots, birthmarks). For this purpose, a photo of the designated skin area is taken with the camera of the smartphone. The image is then run through our clinically proven neural network. The risk status for skin cancer is indicated by an easy to understand 3 color code (low, medium, high risk). SkinScreener is available as a free download, and users will receive a limited number of free scans after registration. Additional scans are offered as a paid subscription for a period of 3 or 12 months, or as a paid number of scans. Before the scan, users must perform a camera test to ensure a working camera and good photo quality. The scan is performed according to the instructions for use. The algorithm calculates the risk assessment for skin cancer at the designated skin area: Green: LOW RISK Yellow: MEDIUM RISK or Red: HIGH RISK Based on the risk assessment, users are advised to consult a dermatologist for further examination to obtain an accurate medical diagnosis. Users with a "MEDIUM RISK" or "HIGH RISK" rating should see the dermatologist earlier than the recommended preventive dermatological examinations. The specialist will then verify the results by further specialist examinations. In the LOW RISK assessment, the skin lesion should be monitored regularly and rescanned at least once a month. Nevertheless, SkinScreener users should visit their dermatologist for a regular annual dermatological examination. SkinScreener is registered as a Class I medical device (European Directive 93/42/EEC) and clinically validated by a study at the Medical University of Graz. SkinScreener is intended for adult users with Fitzpatrick skin type I (ivory) to IV (light brown). SkinScreener must not be used on children. We take the protection of your data seriously! Your data will exclusively be stored on European servers and according to the EU Data Protection Directive (GDPR). Your pictures will only be stored anonymously on our servers and will be used to improve our app and for research purposes. Disclaimer: This app does not replace a physical examination by a doctor. Always seek professional medical advice, especially before making medical decisions. SkinScreener cannot replace a dermatological examination, it does not make a diagnosis and cannot replace the visit of a medical professional. Indication: To evaluate a lesion on human skin for possible visual signs of skin cancer using a three-level classification (LOW RISK, MEDIUM RISK, or HIGH RISK). General terms and conditions: https://skinscreener.at/en/terms-and-conditions/ Privacy policy: https://skinscreener.at/en/privacy-policy/